UNSPSC 51432203: Dihydralazine hydrochloride

This classification denotes an antihypertensive agent with the molecular formula C8H10N6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OVG1TP7A10, chemically known as 2,3-dihydrophthalazine-1,4-dione dihydrazone monohydrochloride but more generally known as dihydralazine hydrochloride, which bears US NIH Compound Identifier 198456. European Medicines Agency schedules Dihydralazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01701MIG.

Most nations, for tariff and trade purposes, schedule dihydralazine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, DIHYDRALAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dihydralazine hydrochloride bears US NLM identifiers UMLS ID C3273349 and NCI Concept Code C97308. SMILES: C1CCC2C(C1)C(NNC2NN)NN.CL.

UNSPSC 51432203 Dihydralazine hydrochloride, a Commodity code, represents emergency pharmaceuticals and life-support medications that state and local emergency medical services and fire departments procure through sealed bids. While the code nominally identifies a single active pharmaceutical ingredient, state and local buyers typically solicit bundles of critical injectable medications under broader emergency-medicine procurement codes and narrower commodity specifications. The scope includes multiple-unit purchases of vials and injections with strict expiration-date requirements—typically nine months or more from acceptance—and rapid delivery windows, often within ten calendar days of order. Issuers in this space are primarily city and county fire departments and emergency medical services divisions, procuring on behalf of operational units like Tampa Fire Rescue; these agencies operate under formal purchasing departments and post sealed bids through electronic procurement portals with firm-price requirements, delivery-location specifications (freight on board to the named jurisdiction), and comprehensive warranty and replacement provisions.

The City of Tampa's Purchasing Department posted a recent sealed-bid solicitation (26P00188, due April 8, 2026) for Advanced Life Support Medications to serve Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000 and a one-year term plus two one-year renewal options. This opportunity required vendors to supply four specific medication line items including 370 units of Labetalol HCl 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with delivery within ten calendar days and a nine-month minimum shelf life. The bid included a Small Local Business Enterprise sheltered-market designation with a 5 percent discount cap of $10,000, required Safety Data Sheets compliant with OSHA standards, and accessibility documentation conforming to WCAG 2.2 Level AA and Section 508 federal standards. The award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening.